Parsortix liquid biopsy boosted by independent study while awaiting FDA clearance
Results of the study suggest Parsortix is better able to isolate cancer cells that indicate tumours have metastasised (Credit: Shutterstock/crystal light)
NS Medical Devices is using cookies
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X